CLDF to Support Free HCV Testing at 60 Walgreens Stores across the U.S.
CLARK, N.J., May 19, 2015 /PRNewswire/ — The Chronic Liver Disease Foundation (CLDF) announced today that it’s collaborating with Walgreens
to offer free hepatitis C (HCV) testing with the OraQuick® HCV Rapid
Test at more than 60 Walgreens retail pharmacies in 12 major cities
throughout the country.
The program, which is slated to launch this August
and run through January 2016, will offer free rapid HCV testing on
specific days and times each week to patients at risk for HCV. Rapid
testing and patient education will be conducted by trained healthcare
professionals on site at each retail location and individuals who test
positive will be linked directly to one of CLDF’s 75 Hepatology Centers
of Expertise throughout the U.S.
“The rapid hepatitis testing program demonstrates
our commitment to helping patients access important information that can
help to improve their health,” said Glen Pietrandoni, RPh, AAHIVP,
senior director, virology, Walgreens. “We are proud to collaborate with
the Chronic Liver Disease Foundation on this initiative. Through this
testing program we can help people become educated on the risk factors,
identify people infected with HCV and help them get linked to
“Today, approximately 5.2 million Americans have
hepatitis C and the vast majority does not know it,” said Dr. Willis C.
Maddrey, President of the Chronic Liver Disease Foundation. “However,
new therapies are now available that can effectively treat and cure
Each year, about 17,000 Americans become infected
with hepatitis C. Up to 75 percent of people with chronic hepatitis C
infection were born during 1945-1965, and up to three out of four people
infected with hepatitis C are unaware of their infection.
OraQuick® HCV is the first and only FDA-approved
and CLIA-waived point of care test for detection of HCV infection in
at-risk individuals. The simple, accurate platform enables healthcare
providers to deliver an accurate diagnosis in 20 minutes, using
venipuncture or fingerstick blood. The test is manufactured by OraSure
in Bethlehem, Pa.
About the Chronic Liver Disease Foundation
Established in 2001, the Chronic Liver Disease Foundation is a nonprofit
501(c)(3) educational organization dedicated to providing hepatology
related continuing medical education, news and information to healthcare
professionals across the US. The CLDF is led by a Board of Trustees
comprised of nationally renowned liver disease specialists. Furthermore,
the CLDF believes that educational programs should be developed by the
specialists who are actively involved in the research, treatment and
management of a disease. As such the CLDF has developed a network of 75
Centers of Educational Expertise and multiple Advisory Boards who are
actively involved in program creation related to specific disease topics
which include; hemochromatosis, hepatic encephalopathy, hepatitis B,
hepatitis C, hepatocellular carcinoma, HIV co-infection, liver
transplantation and NASH/NAFLD. The CLDF’s educational opportunities are
offered in a variety of formats including an interactive web site, live
meetings, teleconferences, print pieces, webcasts and other electronic
mediums. For more information, please visit www.chronicliverdisease.org.
Media Contact:Contact:Alessandra LaMastro for CLDF973email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/chronic-liver-disease-foundation-and-walgreens-to-launch-hepatitis-c-testing-campaign-300085539.html
Copyright (C) 2015 PR Newswire. All rights reserved